Cover Image
市場調查報告書

Stelic Institute & Co. 的產品平台分析

Stelic Institute & Co. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 204927
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Stelic Institute & Co. 的產品平台分析 Stelic Institute & Co. - Product Pipeline Review - 2015
出版日期: 2015年07月22日 內容資訊: 英文 29 Pages
簡介

本報告提供Stelic Institute & Co. 的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台分析與最新趨勢,以及暫停中的計劃等資訊。

Stelic Institute & Co. 的基本資料

Stelic Institute & Co. 概要

  • 主要資訊
  • 企業資料

Stelic Institute & Co. :R&D概要

  • 主要的治療範圍

Stelic Institute & Co. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Stelic Institute & Co. :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Stelic Institute & Co. :藥物簡介

  • STNM-01
  • STNM-04
  • 帕金森氏症治療用阻礙糖鎖鏈遺傳基因的小分子
  • 癡呆症治療用阻礙糖鎖鏈遺傳基因的小分子
  • STNM-03
  • STNM-06
  • STNM-09
  • STNM-1510
  • STNM-310

Stelic Institute & Co. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Stelic Institute & Co. :暫停中的計劃

Stelic Institute & Co. :總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07282CDB

Summary

Global Markets Direct's, 'Stelic Institute & Co. - Product Pipeline Review - 2015', provides an overview of the Stelic Institute & Co.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Stelic Institute & Co.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Stelic Institute & Co. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Stelic Institute & Co.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Stelic Institute & Co.'s pipeline products

Reasons to buy

  • Evaluate Stelic Institute & Co.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Stelic Institute & Co. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Stelic Institute & Co.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Stelic Institute & Co. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stelic Institute & Co.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Stelic Institute & Co. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Stelic Institute & Co. Snapshot
    • Stelic Institute & Co. Overview
    • Key Information
    • Key Facts
  • Stelic Institute & Co. - Research and Development Overview
    • Key Therapeutic Areas
  • Stelic Institute & Co. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Stelic Institute & Co. - Pipeline Products Glance
    • Stelic Institute & Co. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Stelic Institute & Co. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Stelic Institute & Co. - Drug Profiles
    • STNM-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-04
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Glycogene 1 for Parkinson's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Glycogene 5 for Dementia
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-03
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-09
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-1510
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • STNM-310
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Stelic Institute & Co. - Pipeline Analysis
  • Stelic Institute & Co. - Pipeline Products by Target
  • Stelic Institute & Co. - Pipeline Products by Route of Administration
  • Stelic Institute & Co. - Pipeline Products by Molecule Type
  • Stelic Institute & Co. - Pipeline Products by Mechanism of Action
  • Stelic Institute & Co. - Dormant Projects
  • Stelic Institute & Co. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Stelic Institute & Co., Key Information
  • Stelic Institute & Co., Key Facts
  • Stelic Institute & Co. - Pipeline by Indication, 2015
  • Stelic Institute & Co. - Pipeline by Stage of Development, 2015
  • Stelic Institute & Co. - Monotherapy Products in Pipeline, 2015
  • Stelic Institute & Co. - Phase II, 2015
  • Stelic Institute & Co. - Preclinical, 2015
  • Stelic Institute & Co. - Discovery, 2015
  • Stelic Institute & Co. - Pipeline by Target, 2015
  • Stelic Institute & Co. - Pipeline by Route of Administration, 2015
  • Stelic Institute & Co. - Pipeline by Molecule Type, 2015
  • Stelic Institute & Co. - Pipeline Products by Mechanism of Action, 2015
  • Stelic Institute & Co. - Dormant Developmental Projects,2015

List of Figures

  • Stelic Institute & Co. - Pipeline by Top 10 Indication, 2015
  • Stelic Institute & Co. - Pipeline by Stage of Development, 2015
  • Stelic Institute & Co. - Monotherapy Products in Pipeline, 2015
  • Stelic Institute & Co. - Pipeline by Top 10 Target, 2015
  • Stelic Institute & Co. - Pipeline by Top 10 Route of Administration, 2015
  • Stelic Institute & Co. - Pipeline by Top 10 Molecule Type, 2015
  • Stelic Institute & Co. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top